SMAD4 mosaicism in juvenile polyposis: Essential contribution of somatic analysis in diagnosis

Sabine Vautier1, Jacques Mauillon2, Nathalie Parodi2

  • 1Department of Genetics, Univ Rouen Normandie, Normandie Univ, Inserm U1245 and CHU Rouen, Rouen, France.

Insights

Juvenile polyposis syndrome (JPS) can be caused by mosaic SMAD4 variants. Detecting this mosaicism is crucial for diagnosing JPS and identifying cancer risks.

Area of Science:

  • Genetics
  • Gastroenterology
  • Oncology

Background:

  • Juvenile polyposis syndrome (JPS) is a rare inherited disorder.
  • It involves hamartomatous polyps in the GI tract.
  • Pathogenic variants in BMPR1A and SMAD4 genes are associated with JPS.

Observation:

  • A 30-year-old male presented with caecum adenocarcinoma and multiple juvenile colon polyps.
  • He had a history of epistaxis since childhood.
  • SMAD4 mosaicism was investigated as a potential cause.

Findings:

  • Next-generation sequencing (NGS) identified a likely pathogenic SMAD4 variant (NM_005359.5:c.1600C>T, p.(Gln534*)) in colon polyps.
  • This variant was detected at low frequency in blood and normal colonic tissue, confirming mosaicism.
  • The findings support a mosaic SMAD4 variant correlating with the patient's JPS phenotype.

Implications:

  • Somatic mosaicism may explain a significant portion of sporadic JPS cases with unidentified variants.
  • This case highlights the diagnostic challenges in detecting mosaicism.
  • Somatic analyses are important for accurate JPS diagnosis and risk assessment.